Immunohematology (49)
All Items
-
Irregular antibodies in pregnancy during the universal anti-RHD prophylaxis era: a survey of Spanish Hospitals
-
Identification and analysis of a novel ABO allele with c.959insC variant in a Chinese blood donor
-
Molecular mechanism of a novel Aweak subtype in Chinese pedigrees: identification and analysis of a large genomic deletion in the promoter upstream distal region of the ABO gene
-
RH gene inversion-recombination as a major mechanism of the D-- phenotype in China
-
Molecularly confirmed para-Bombay (Ah) secretor phenotype with FUT1 c.328G>A and FUT2 c.357C>T mutations: first case report from India
-
Complete D epitope expression of the most common weak D types 15, 25, 33, and 72 in the Chinese population
-
Neonatal alloimmune thrombocytopenia due to anti-HPA-1b and anti-HLA antibodies: diagnostic and transfusion management of a clinical case
-
Multicenter evaluation of soluble CD38: neutralizing anti-CD38 pan-reactivity to enable alloantibody detection
-
Passive transfer of silent red blood cell autoantibodies via the placenta and breast milk: a case report
-
Non-invasive fetal HPA genotyping by UMI-NGS: a robust method for antenatal diagnosis including 48 fetal DNA markers
-
A novel A allele with c.575T>C variant in glycosyltransferase A leads to ABO discrepancy
-
Delayed hemolytic transfusion reaction associated with anti-Au(a) antibody in a young male with beta-thalassemia
-
Molecular characterization of variant D antigen expression among 56,445 blood donors in East India
-
When is ABO-incompatible plasma safe to transfuse? Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products
-
Partial s antigen expression in GP(B-A-B) hybrid glycophorins and the corresponding in vitro expression study
-
Identification of a novel ABO*O.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual
-
Post-transplant pediatric autoimmune hemolytic anemia: donor vs donor or recipient vs self?
-
Rh disease in Mexico: evaluating regional and institutional differences in treatment availability and disease management
-
CD36 antibodies in isoimmunised African-origin pregnant women: three years experience in Spain
-
ELP protocol: an original approach for the mitigation of anti-CD38 interference
-
A case of trisomy 9 with mixed-field ABO blood type
-
Description of the first case of c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele
-
Defining the breakpoints of hybrid blood group alleles
-
Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden
-
Patients with red cell antibodies: registries improve patient care by increasing patient safety, reducing costs, and enabling health information exchange
49 Items